Partial prevention of procarbazine induced germinal cell aplasia in rats by sequential GnRH antagonist and testosterone administration.

No abstract is available for this paper.

• Publication year

  1988

• Venue

  Cancer Research

• Publication date

  1988-08-01

• Fields of study

  Biology, Medicine

• Identifiers
  PMID 3134124
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Effect of recombinant human granulocyte-macrophage colony-stimulating factor on hematopoietic reconstitution after high-dose chemotherapy and autologous bone marrow transplantation.

  1988cited by this paper
• Protective effects of analogs of luteinizing hormone-releasing hormone against x-radiation-induced testicular damage in rats.

  1987cited by this paper
• In vivo stimulation of granulopoiesis by recombinant human granulocyte colony-stimulating factor.

  1987cited by this paper
• Suppression of the intratesticular testosterone is associated with quantitative changes in spermatogonial populations in intact adult rats.

  1986influential reference
• Protection from procarbazine-induced damage of spermatogenesis in the rat by androgen.

  1986cited by this paper
• D-Tryptophan-6 analog of luteinizing hormone-releasing hormone as a protective agent against testicular damage caused by cyclophosphamide in baboons.

  1985cited by this paper
• Effect of a luteinizing hormone releasing hormone agonist given during combination chemotherapy on posttherapy fertility in male patients with lymphoma: preliminary observations.

  1985cited by this paper
• Species differences in the sensitivity to the antitesticular effects of [Ac-D-NAL(2)1, 4FD-Phe2, D-Trp3,D-Arg6]-LHRH, a potent LHRH antagonist.

  1984cited by this paper
• Morphological pattern of response after administration of procarbazine: alteration of specific cell associations during the cycle of the seminiferous epithelium of the rat.

  1983cited by this paper
• Leydig cell function in patients with testicular cancer during and after chemotherapy.

  1983cited by this paper
• A rat model for chemotherapy-induced male infertility.

  1983cited by this paper
• Superactive gonadotropin-releasing hormone agonists.

  1983cited by this paper
• Regulation of the seminiferous epithelium.

  1982cited by this paper
• The effects of cancer and cancer therapy on male fertility.

  1981cited by this paper
• Protection from cyclophosphamide-induced testicular damage with an analogue of gonadotropin-releasing hormone.

  1981cited by this paper
• Purification and characterization of androgen binding protein from the rat epididymis.

  1980cited by this paper
• Persistence of complete spermatogenesis in the presence of low intratesticular concentrations of testosterone.

  1979cited by this paper
• Spermatogenic response to vitamin A in vitamin A deficient rats.

  1979cited by this paper
• Early effects of procarbazine (N-isopropyl-L-(2-methylhydrazino)-p-toluamide hydrochloride) on rat spermatogenesis.

  1979cited by this paper
• Effects of procarbazine on spermatogenesis determined by velocity sedimentation cell separation technique and serial mating.

  1972cited by this paper
• Lectures on biostatistics

  1972cited by this paper
• Radioimmunoassay for Plasma Testosterone

  1972cited by this paper
• CELL CYCLE PROPERTIES OF DIFFERENTIATING SPERMATOGONIA IN ADULT SPRAGUE‐DAWLEY RATS

  1971cited by this paper
• DEFINITION OF THE STAGES OF THE CYCLE OF THE SEMINIFEROUS EPITHELIUM IN THE RAT

  1952cited by this paper

• Male Hypogonadism Due to Cancer and Cancer Treatments

  2017cites this paper
• Protective effect of N-Acetylcysteine (NAC) on human spermatozoa exposed to etoposide, a chemotherapeutic agent

  2015cites this paper
• Novel Drug Therapies for Fertility Preservation in Men Undergoing Chemotherapy: Clinical Relevance of Protector Agents.

  2015cites this paper
• Protective effect of N - acetylcysteine (NAC) on human spermatozoa exposed to etoposide, a chemotherapeutic agent

  2015cites this paper
• IMPROVEMENT IN SPERM PARAMETERS AFTER USING GONADOTROPINRELEASING HORMONE ANALOGUE IN BUSULFAN TREATED PREPUBERTAL MICE

  2014cites this paper
• Protective effects of subchronic caffeine administration on cisplatin induced urogenital toxicity in male mice.

  2012cites this paper
• Hormonal suppression for fertility preservation in the male

  2011cites this paper
• Testosterone mediated partial recovery of carboplatin induced reproductive toxicity in male wistar rats

  2010cites this paper
• Focus on Fertility Preservation Hormonal suppression for fertility preservation in males and females

  2008cites this paper
• The Effects of Chemotherapy and Radiotherapy on Testicular Function

  2007cites this paper
• Strategies for preservation of ovarian and testicular function after immunosuppression.

  2004cites this paper
• Preservation of spermatogenesis in spinal cord injured rats with exogenous testosterone. Relationship with serum testosterone levels and cellular localization of cAMP responsive element modulator.

  2004cites this paper
• Regulation of Male Germ Cell Apoptosis by Sphingosine-1-Phosphate

  2004cites this paper
• Effects Of Exogenous Testosterone On Testicular Function During The Chronic Phase Of Spinal Cord Injury: Dose Effects On Spermatogenesis And Sertoli Cell And Sperm Function

  2004cites this paper
• Male Hypogonadism Resulting From Cancer and Cancer Treatments

  2004cites this paper
• Male Hypogonadism

  2004cites this paper
• Suppression of testosterone stimulates recovery of spermatogenesis after cancer treatment.

  2003cites this paper
• Investigation of suppression of the hypothalamic-pituitary-gonadal axis to restore spermatogenesis in azoospermic men treated for childhood cancer.

  2002influential citation
• Fertility and progeny.

  2002cites this paper
• Fertility preservation and management of gonadal failure associated with lymphoma therapy

  2002cites this paper
• Protección de la espermatogénesis en pacientes con cáncer de testículo en tratamiento con radioterapia y/o quimioterapia adyuvante

  2002cites this paper
• Paediatric Update Fertility and progeny

  2002cites this paper
• Fertilité après chimiothérapie anticancéreuse

  2002cites this paper
• Faculdade de Medicina da Universidade do Porto

  2001cites this paper
• Testicular function following chemotherapy.

  2001cites this paper
• Advances in Brief Hormonal Treatment after Cytotoxic Therapy Stimulates Recovery of Spermatogenesis 1

  1999cites this paper
• Hormonal treatment after cytotoxic therapy stimulates recovery of spermatogenesis.

  1999cites this paper
• Pharmacological protection of the gonads.

  1999cites this paper
• Effects of spinal cord injury on spermatogenesis and the expression of messenger ribonucleic acid for Sertoli cell proteins in rat Sertoli cell-enriched testes.

  1999cites this paper
• Hormonal stimulation of the recovery of spermatogenesis following chemo‐ or radiotherapy

  1998cites this paper
• Gonadal damage from chemotherapy and radiotherapy.

  1998cites this paper
• Hormonal Protection of Spermatogenic Stem Cells Against Cytotoxic Agents

  1998cites this paper
• Hormone treatment after irradiation stimulates recovery of rat spermatogenesis from surviving spermatogonia.

  1997cites this paper
• Prevention of gonadal damage during cytotoxic therapy.

  1997cites this paper
• Relationship among hormonal treatments, suppression of spermatogenesis, and testicular protection from chemotherapy-induced damage.

  1996cites this paper
• Effects of cis-platinum and luteinizing hormone releasing hormone analogues on rat spermatogenesis. A morphologic and flow cytometric study.

  1996cites this paper
• [Effects of anti-cancer agents on cultured rat Sertoli cells].

  1995cites this paper
• Rapid protection of rat spermatogenic stem cells against procarbazine by treatment with a gonadotropin-releasing hormone antagonist (Nal-Glu) and an antiandrogen (flutamide).

  1995cites this paper
• The role of LHRH-analogues in protecting gonadal functions during chemotherapy and irradiation.

  1993cites this paper
• Protection by gonadal steroid hormones against procarbazine-induced damage to spermatogenic function in LBNF1 hybrid rats.

  1993cites this paper
• Alteration of mRNA transcript levels of rat testicular cells following procarbazine administration.

  1993cites this paper
• Maintenance of spermiogenesis by exogenous testosterone in rats treated with a GnRH antagonist: relationship with androgen-binding protein status.

  1993cites this paper
• Lead acetate does not impair secretion of Sertoli cell function marker proteins in the adult Sprague Dawley rat.

  1992cites this paper
• Radiation therapy versus combination chemotherapy in the treatment of early-stage Hodgkin's disease: seven-year results of a prospective randomized trial.

  1991cites this paper
• Protection of rat spermatogenic epithelium from damage induced by procarbazine chemotherapy.

  1990cites this paper
• The use of chemotherapy in the treatment of Hodgkin's disease.

  1990cites this paper
• Protection of gonadal function from cytotoxic chemotherapy and irradiation.

  1990cites this paper
• Prolonged suppression of spermatogenesis by oestrogen does not preserve the seminiferous epithelium in procarbazine-treated rats.

  1990cites this paper
• Experimental cryptorchidism protects against long-term 2,5-hexanedione-induced testicular germ cell loss in the rat.

  1990cites this paper
• Characterization of cis-platinum-induced Sertoli cell dysfunction in rodents.

  1989cites this paper
• Effect of sexual maturity on testicular injury subsequent to procarbazine administration in rats.

  1988cites this paper